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FIGURE 1 Echocardiographic Determinants of Fitness Response to Exercise Training
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(A) Baseline characteristics of study participants stratiﬁed by training response. (B) Association between baseline echocardiographic measurements and nonresponse
to exercise training. Values are mean (SD) or %, unless otherwise noted. BP ¼ blood pressure; CI ¼ conﬁdence interval; IQR ¼ interquartile range; VO2 ¼ volume of
oxygen consumed.
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1058may be better suited to adapt to exercise with phys-
iological remodeling as compared to those with
adverse LV remodeling at baseline.
Our study ﬁndings could have important implica-
tions. The present study suggests that low ﬁt partici-
pants with adverse LV remodeling, who are at a greater
risk for nonresponse to exercise, may require alterna-
tive exercise training strategies (e.g., higher intensity
and/or dose of exercise training) to improve ﬁtness.
Our study represents an important step in this
direction with characterization of distinct cardiac
phenotypes associated with heterogeneity in re-
sponse to exercise training. Further studies are
needed to characterize the underlying cardiovascular
mechanisms and optimal treatment for the nonre-
sponse to moderate-intensity exercise training.Ambarish Pandey, MD
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Present the Next
Challenge After TAVRIn the presence of aortic stenosis, the left ventricle
(LV) faces a double challenge: a valvular load and
an arterial load (1). Transcatheter aortic valve
replacement (TAVR) has now become a safe and
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1059effective alternative to surgery in patients with a
contraindication or at high risk (2). Because patients
considered for TAVR are elderly, implying that they
often have a markedly remodeled aorta, the arterial
component of the LV load is likely to be sizable; yet,
the precise impact of aortic remodeling on cardiac
outcomes after TAVR has never been tackled. We
examined the effect of ascending aortic calciﬁcations
(AAC) measured by computed tomography (CT) on a
composite endpoint encompassing cardiac mortality
(from heart failure [HF], myocardial infarction
[MI], or sudden death) and hospitalization for HF
following TAVR with Edwards Sapien devices (Ed-
wards Lifesciences, Irvine, California) in 127 consecu-
tive patients. Patients provided written informed
consent and the study received ethical committee
approval.FIGURE 1 Impact of Aortic Calciﬁcations on Cardiac Outcomes After
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Aortic stiffness is closely related to left ventricular (LV) function, but m
concerns valvular load (left panel). Once the aortic stenosis is relieved,
SBP ¼ systolic blood pressure.Image acquisition was performed on a Brilliance
64-slice CT scanner (Philips, Healthcare, North And-
over, Massachusetts). Calciﬁcations of the thoracic
aorta were individually delineated from the aortic
sinus to the left subclavian artery with a semi-
automatic segmentation tool (IntelliSpace Portal,
Philips Healthcare) (3). For each patient, the total
volume of the delineated AAC was calculated.
AAC was considered in turn as a categorical vari-
able (tertiles) and as a continuous variable for statis-
tical analysis; AAC ranged from 0 to 21,700 mm3.
Transapical approach, peripheral artery disease, and
previous coronary artery bypass graft surgery were
more frequent with increasing AAC levels. No differ-
ence was observed for other variables, in particular
comorbidities, Logistic European System for Cardiac
Operative Risk Evaluation (EuroSCORE), or ejectionTAVR
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ost of the preoperative work-up before transcatheter aortic valve replacement (TAVR)
aortic (Ao) load becomes critical for LV function (right panel). DBP ¼ diastolic blood pressure;
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1060fraction (EF). After a median follow-up of 907 days
(range 0 to 1,912 days), we observed 24 cardiac deaths
(14 HF, 1 MI, 9 sudden death) and 46 hospitalizations
for HF, leading to a total of 54 composite endpoints.
Seven patients died during the ﬁrst week and were
considered as periprocedural events.
AAC markedly inﬂuenced the occurrence of the
outcome in univariable analysis (tertiles 3 and 2 vs. 1
hazard ratio [HR]: 2.61; 95% conﬁdence interval [CI]:
1.31 to 5.20; p ¼ 0.006; þ1 Log increment of ACC
HR: 1.70; 95% CI: 1.15 to 2.50; p ¼ 0.007). Potential
confounders considered were either univariate pre-
dictors of events or signiﬁcant correlates of AAC.
In a ﬁrst multivariable Cox regression model ad-
justed for arterial approach, peripheral artery disease,
and previous coronary artery bypass grafting (or pre-
valence of coronary artery disease), AAC remained
predictive of the outcome (tertiles 3 and 2 vs. 1 HR:
2.50; 95% CI: 1.23 to 5.09; p ¼ 0.001; þ1 Log
increment of ACC HR: 1.70; 95% CI: 1.10 to 2.61;
p ¼ 0.016). Similar ﬁndings were observed in 2 other
multivariable models, 1 adjusted for EuroSCORE and
diabetes and the other adjusted for post-procedural
grade 2 aortic regurgitation and calciﬁcation of the
aortic ring. A sensitivity analysis performed after ex-
clusion of periprocedural events led to similar results.
This study shows that the extent of AAC is a strong
independent predictor of cardiac outcome after
TAVR. This is not likely to be due to a higher occur-
rence of MI; indeed, outcome was mainly driven by
HF while only 1 fatal MI was observed, which arose in
the periprocedural period and was not accounted for
in the sensitivity analysis. Furthermore, adjustments
for “coronary history” did not change the results. We
believe that the worse cardiac prognosis associated
with a high AAC score mainly reﬂects the conse-
quences of aortic stiffening on LV function (Figure 1)
(4). This is probably critical in TAVR patients, because
they often have aged vessels. For the moment,
methods to “destiffen” the aorta are limited, and AAC
should be considered primarily as a new powerful
criterion to reﬁne risk stratiﬁcation in usually
severely ill patients in whom the best option is not
easy to determine.Brahim Harbaoui, MD
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Drug Development
for Heart FailureI read with great interest the thoughtful editorial
by Greene and Gheorghiade (1) proposing rigorous
testing in a small homogenous cohort of patients
hospitalized with heart failure in early phase trials in
order to elucidate the mechanisms of action and
beneﬁt for maximal pairing of the new therapy with
subsequent phase III trial population. Considering
that the last heart failure drug approved by the Food
and Drug Administration was the combination of
hydralazine and isosorbide dinitrate in 2005, this
concept could be equally applied to outpatient heart
failure population.
In assessing the merit of this innovative approach,
however, 2 issues need to be taken into consideration:
1. Even if the new therapy is of proven beneﬁt in
the highly selected cohort, it will need to be
tested in a wider less selected cohort and having
more insight into the mechanism of action may
not necessarily help in selecting a wider patient
population.
2. Differences between trials and community patients
have long been recognized (2) and adoption of the
